| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Plus Therapeutics, Inc. (PSTV) has 7 insiders with recent SEC Form 4 filings, including 10 buys and 12 sells. PSTV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 397.8K | $2.43M | - | |
| CEO | 339.8K | $2.08M | - | |
| Dir | 297.8K | $1.82M | - | |
| Dir | 297.8K | $1.82M | - | |
| Dir | 297.8K | $1.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2018 | Postfinance AG | 10% Owner | Sell | 236,155 | $0.34 | $81,001.37 | -2.2% | |
| Jan 11, 2018 | Swissquote Bank SA | 10% Owner | Sell | 188,426 | $0.37 | $69,055.42 | -0.3% | |
| Aug 10, 2016 | Harris John David | VP And Gm Cell Therapy | Buy | 2,500 | $2.03 | $5,075.00 | +55.6% | |
| Jun 14, 2016 | Naughton Gail K | Director | Buy | 1,000 | $2.10 | $2,100.00 | +71.4% | |
| Jun 14, 2016 | Rickey David | Director | Buy | 5,000 | $2.10 | $10,500.00 | +10.0% | |
| May 13, 2016 | Harris John David | VP And Gm Cell Therapy | Buy | 2,000 | $2.71 | $5,420.00 | New | |
| Mar 9, 2016 | Rickey David | Director | Buy | 150,000 | $0.19 | $28,290.00 | +17.2% | |
| Sep 3, 2015 | Thompson Tommy G50 | Director | Buy | 25,449 | $0.37 | $9,530.65 | +43.8% | |
| Sep 2, 2015 | Hayden Jeremy B.63 | General Counsel &VP Of Bd | Buy | 8,200 | $0.36 | $2,911.00 | +45.6% | |
| Aug 28, 2015 | Rickey David | Director | Buy | 56,000 | $0.31 | $17,628.80 | +6.9% |